September 26, 2022
Loading...
You are here:  Home  >  Regions  >  East Ventura County  >  Current Article

Amgen gets approval for arthritis drug biosimilar

IN THIS ARTICLE

Biotech giant Amgen received its third U.S. approval for a biosimilar Dec. 6, a competitor for Johnson & Johnson rheumatoid arthritis drug Remicade. Worldwide sales of Remicade have fallen 18 percent in the first nine months of 2019 to $3.35 billion, but still make up more than 10 percent of Johnson & Johnson’s pharmaceutical revenue.…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.